6533b826fe1ef96bd1284d07
RESEARCH PRODUCT
Abincol® (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01), an oral nutraceutical, pragmatic use in patients with chronic intestinal disorders.
Luigi BonavinaAndrea AriniLeonardo FicanoDonato IannuzzielloLuigi PasqualeSalvo Emanuele AragonaGiorgio CiprandiRaffaele AnnicchiaricoBucci AntongiulioArrigo ArrigoniStefano BargiggiaPaolo Beretta Berni Canani MarcellaAntonino BertinoFilippo BovaGiampaolo BresciCarmelo BudaSalvatore CamilleriSte-fania CaronnaGregorio Cavallo Chahin Nabil JamilVirgilio ClaraSelvaggio CorradoGiovanni CozzoliUgo CrescenziRaimondo DarioFrancesco D’arpaAntonello DattolaDavide DeianaArmando Dell’anna Di Fenza Sergio Di Lorenzo Fernando Di Napoli An-geloVittorio D’onofrioGiovanni FerriniDomenico FerrulliRoberto FinizioNicola Gaffuri Garcea Maria RitaSalvatore GenovaPietro GiorgioMaurizio GiovannoneGiuliana GiuseppeGiovanni GuarnieriRenzo GullottaGiuseppe LeonardiGiovanni MagrìTammaro MaistoMariagrazia MancinoGianpiero ManesSantino MarchiRenato MarinMaria MarinoManuele MazziFrancesca Menasci Morabito Lo Prete AntonioFrancesca Murer Neri Bortoluzzi FrancescoSocrate PallioAntonio PalmaDa-vide PardocchiAntonio Pinto Pio Palieri AntonioAntonio PisaniAntonello PriviteraRaffaela PulitanòRossella PumpoFrancesco QuatraroIvana RaguzziCesarina RainisioGiulia RazzoliniOlimpia RevelloNicita RinaldoGiuseppe RivelliniGuidorenato SabadiniMarcello SalviaGennaro SarrantonioEdoardo SavarinoAntonella ScarcelliPietro SchettinoAngelo SchicchiLuigi SchiffinoLuca SediariEndrit ShainiCristiano SpadaFernando SpinelliLorenza TifiClaudio TrovatoRoberto VassalloMaurizio VintiFrancesca ZappatoreClaudio. Zullisubject
Diverticular DiseasesMaleirritable bowel syndromeLactobacillus delbrueckiiProbioticsdiverticular diseaseAdministration OralInflammatory bowel disease irritable bowel syndrome diverticular disease probiotic surveyMiddle AgedInflammatory Bowel DiseasesLactobacillusinflammatory bowel diseaseChronic DiseaseDietary SupplementsHumansFemaleOriginal ArticlesurveySelf ReportprobioticLactobacillus plantarumdescription
Chronic intestinal disorders (CID), including inflammatory bowel disease (IBD), such as ulcerative colitis and Crohn’s disease, irritable bowel syndrome (IBS), and diverticular disease (DD), are diseases that relapse episodes. There is evidence that patients with CID have intestinal dysbiosis, so probiotics may counterbalance the impaired microbiota. Therefore, the current survey evaluated the efficacy and safety of Abincol®,an oral nutraceuticalcontaining a probiotic mixture with Lactobacillus plantarum LP01 (1 billion of living cells), Lactobacillus lactis subspecies cremoris LLC02 (800 millions of living cells), and Lactobacillus delbrueckii LDD01 (200 millions of living cells), in 3,460 outpatients (1,660 males and 1,800 females, mean age 55 years) with chronic intestinal disorders. Patients took 1 stick/daily for 8 weeks. Abincol® significantly diminished the presence and the severity of intestinal symptoms and improved stool form. In conclusion, the current survey suggests that Abincol® may be considered an effective and safe therapeutic option in the management of patients with chronic intestinal disorders. (www.actabiomedica.it)
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2019-07-02 | Acta bio-medica : Atenei Parmensis |